发明名称 |
TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS |
摘要 |
A method of treating cancer is disclosed comprising administering to a patient in need of such treatment a RXR agonist at a level below the RAR activating threshold and at or above the RXR effective dose. |
申请公布号 |
US2016120826(A1) |
申请公布日期 |
2016.05.05 |
申请号 |
US201614994025 |
申请日期 |
2016.01.12 |
申请人 |
IO Therapeutics, Inc. |
发明人 |
Chandraratna Roshantha A. |
分类号 |
A61K31/192;A61K31/337;A61K31/282 |
主分类号 |
A61K31/192 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating breast cancer comprising administering to a patient in need of such treatment a retinoid X receptor (RXR) agonist at a dose below the Retinoic Acid Receptor (RAR) activating threshold and at or above the RXR effective dose, the RXR agonist has the chemical structure where R is H, lower alkyl or 1 to 6 carbons, or a pharmaceutically acceptable salt of the compound, and the dose of the RXR agonist is from about 0.01 to about 100 mg/m2/day. |
地址 |
San Juan Capistrano CA US |